Replies to post #145130 on Biotech Values

[DewDiligence]

Too funny—ILNS sues a “top tier global pharma company” for non-payment of a $2M “milestone” pertaining to AD, but doesn’t say who the defendant is:

http://finance.yahoo.com/news/intellect-neurosciences-files-lawsuit-against-133500118.html

In prior threads on this board, various posters predicted that ILNS would receive nothing from its purportedly valuable IP in AD.